(Q36779337)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17406160%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

IBS--review and what's new (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17406160%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Amy Foxx-Orenstein

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17406160%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

26 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17406160%20AND%20SRC:MED&resulttype=core&format=json

MedGenMed : Medscape general medicine

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17406160%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17406160%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17406160%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17406160%20AND%20SRC:MED&resulttype=core&format=json

Effects of intracolonic opioid receptor agonists on polymodal pelvic nerve afferent fibers in the rat.

28 December 2019

cites work

1 reference

12 December 2020

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

1 reference

12 December 2020

Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat.

1 reference

12 December 2020

Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome

1 reference

12 December 2020

Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures

1 reference

12 December 2020

The impact of irritable bowel syndrome on health-related quality of life

1 reference

12 December 2020

Familial association in adults with functional gastrointestinal disorders

1 reference

12 December 2020

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

1 reference

12 December 2020

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

12 December 2020

Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits

1 reference

12 December 2020

The role of serotonin in the pathophysiology of irritable bowel syndrome.

1 reference

12 December 2020

Irritable bowel syndrome: toward a cost-effective management approach.

1 reference

12 December 2020

Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters

1 reference

12 December 2020

Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study

1 reference

12 December 2020

Adverse effects of laxatives

1 reference

12 December 2020

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

1 reference

12 December 2020

Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology

1 reference

12 December 2020

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

A role for inflammation in irritable bowel syndrome?

1 reference

12 December 2020

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Clinical assessment of irritable bowel syndrome

1 reference

12 December 2020

Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

1 reference

12 December 2020

Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women

1 reference

12 December 2020

The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review

1 reference

12 December 2020

Evidence-based position statement on the management of irritable bowel syndrome in North America

1 reference

12 December 2020

Systematic review on the management of irritable bowel syndrome in North America.

1 reference

12 December 2020

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

1 reference

12 December 2020

AGA technical review on irritable bowel syndrome

1 reference

12 December 2020

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans

1 reference

12 December 2020

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

1 reference

12 December 2020

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

1 reference

12 December 2020

Small bowel bacterial overgrowth, celiac disease, and IBS: what are the real associations?

1 reference

12 December 2020

Diagnosing irritable bowel syndrome.

1 reference

12 December 2020

The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.

1 reference

12 December 2020

Irritable bowel syndrome: new and emerging therapies

1 reference

12 December 2020

SSRIs in IBS: sensing a dash of disappointment

1 reference

12 December 2020

G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia

1 reference

12 December 2020

Treating irritable bowel syndrome: overview, perspective and future therapies

1 reference

12 December 2020

Antidepressants in IBS: are we deluding ourselves?

1 reference

12 December 2020

The functional gastrointestinal disorders and the Rome III process

1 reference

12 December 2020

Functional bowel disorders

1 reference

12 December 2020

Serotonin and its implication for the management of irritable bowel syndrome.

1 reference

12 December 2020

Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome

1 reference

12 December 2020

Natural history of irritable bowel syndrome and durability of the diagnosis

1 reference

12 December 2020

When to conduct testing in patients with suspected irritable bowel syndrome

1 reference

12 December 2020

Small intestinal bacterial overgrowth and irritable bowel syndrome.

1 reference

12 December 2020

Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats

1 reference

12 December 2020

Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron

1 reference

12 December 2020

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

1 reference

12 December 2020

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

1 reference

12 December 2020

A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders

1 reference

12 December 2020

Durability of the diagnosis of irritable bowel syndrome based on clinical criteria.

1 reference

12 December 2020

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

1 reference

12 December 2020

Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis

1 reference

12 December 2020

Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome

1 reference

12 December 2020

Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome

1 reference

12 December 2020

The brain-gut axis in irritable bowel syndrome--clinical aspects.

1 reference

12 December 2020

Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials

1 reference

12 December 2020

New pathophysiological mechanisms in irritable bowel syndrome

1 reference

12 December 2020

Is there a SERT-ain association with IBS?

1 reference

12 December 2020

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women

1 reference

12 December 2020

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

1 reference

12 December 2020

The need for a new medical model: a challenge for biomedicine

1 reference

12 December 2020

Towards positive diagnosis of the irritable bowel

1 reference

12 December 2020

Breath hydrogen testing in bacterial overgrowth of the small intestine.

1 reference

12 December 2020

Diagnostic value of the Manning criteria in irritable bowel syndrome

1 reference

12 December 2020

Role of CRF in stress-related alterations of gastric and colonic motor function

1 reference

12 December 2020

Evaluation of patients who meet clinical criteria for irritable bowel syndrome.

1 reference

12 December 2020

Medical costs in community subjects with irritable bowel syndrome

1 reference

12 December 2020

Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial.

1 reference

12 December 2020

Gastrointestinal illness and the biopsychosocial model

1 reference

12 December 2020

The lactulose breath hydrogen test and small intestinal bacterial overgrowth

1 reference

12 December 2020

Impact of irritable bowel syndrome on quality of life

1 reference

12 December 2020

Review article: irritable bowel syndrome

1 reference

12 December 2020

Quality of life in patients with different types of functional constipation

1 reference

12 December 2020

Presidential address: Gastrointestinal illness and the biopsychosocial model

1 reference

12 December 2020

Evidence of a genetic contribution to functional bowel disorder.

1 reference

12 December 2020

Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception

1 reference

12 December 2020

Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis

1 reference

12 December 2020

Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria.

1 reference

12 December 2020

The enteric nervous system: a second brain

1 reference

12 December 2020

Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants.

1 reference

12 December 2020

Functional bowel disorders and functional abdominal pain

1 reference

12 December 2020

Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome

1 reference

12 December 2020

Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis

1 reference

12 December 2020

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

1 reference

12 December 2020

A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome

1 reference

12 December 2020

What does the future hold for irritable bowel syndrome and the functional gastrointestinal disorders?

1 reference

12 December 2020

1 reference

12 December 2020

Mechanisms in IBS: something old, something new, something borrowed...

1 reference

12 December 2020

Impairment in work productivity and health-related quality of life in patients with IBS.

1 reference

12 December 2020

Lubiprostone: RU 0211, SPI 0211

1 reference

12 December 2020

Basic and clinical pharmacology of new motility promoting agents

1 reference

12 December 2020

Treatments targeting putative mechanisms in irritable bowel syndrome

1 reference

12 December 2020

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study

1 reference

12 December 2020

Stability of irritable bowel syndrome using a Rome II-based classification

1 reference

12 December 2020

Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients

1 reference

12 December 2020

Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia

1 reference

12 December 2020

Identifiers

1 reference